dactinomycin and Small Cell Lung Carcinoma

dactinomycin has been researched along with Small Cell Lung Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krystal, GW; Xu, H1

Other Studies

1 other study(ies) available for dactinomycin and Small Cell Lung Carcinoma

ArticleYear
Actinomycin D decreases Mcl-1 expression and acts synergistically with ABT-737 against small cell lung cancer cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Sep-01, Volume: 16, Issue:17

    Topics: Antibiotics, Antineoplastic; Apoptosis; Biphenyl Compounds; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; G2 Phase; Humans; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Piperazines; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Small Cell Lung Carcinoma; Sulfonamides; Time Factors

2010